10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Mario Luppi, Robin Foà et al.|The Lancet Haematology|2023Cited by 39